Back to News & Events

Medisafe Finalist in Reuters Pharma Awards

Medisafe has been selected as a finalist in the Most Valuable Digital Therapy for Pharma category in the Reuters Pharma Awards 2022. Medisafe was selected among over 700 submissions due to its innovative approach to medication management and joins the ranks of other leading pharma organizations including Sanofi, Merck, Biogen, Takeda, and others in this prestigious award.

The final winners are set to be announced on December 1, 2022, in Philadelphia.

You may also like

Medisafe PATHWAYS, Eisai and Biogen Recognized for Alzheimer’s Disease Innovation in 2025 MedTech Breakthrough Awards Program

LOS ANGELES, Calif., – May 8, 2025 – MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, 

..Read More

Medisafe Launches VIA: AI Voice Tech That Supercharges Patient Engagement and Slashes Enrollment Friction

BOSTON, MA / ACCESS Newswire / April 22, 2025 / Medisafe today launched VIA (Voice Intelligent Agent) – a breakthrough 

..Read More

Protected: Test prototype

There is no excerpt because this is a protected post.

..Read More

Want to Learn More?

We bring decades of experience to your challenges—and technology and solutions uniquely designed to meet your needs.

Contact Us